Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine approved for persons as young as 12 years old,…
Bavarian Nordic Enters License and Manufacturing Agreement for its Mpox Vaccine with Serum Institute of India
Tech transfer of MVA-BN® will help increase global mpox vaccine manufacturing capacity…
Blue Lake Biotechnology Reports Additional Promising Clinical Data from Ongoing Pediatric Clinical Study of Intranasal RSV Vaccine BLB201
Company leaders to speak today during the open public hearing session of…
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Companys Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals
The World Health Organization (WHO) declared the spread of new Clade Ib…